Northland Capital Partners started coverage on shares
of CONMED (NASDAQ:CNMD) in a research report sent to investors on Friday morning. The firm issued an outperform rating and a $65.00 price target on the stock.
Shares of CONMED (NASDAQ:CNMD) opened at 54.79 on Friday. CONMED has a 52 week low of $35.85 and a 52 week high of $55.98. The stock’s 50-day moving average is $51. and its 200-day moving average is $47.. The company has a market cap of $1.51 billion and a P/E ratio of 50.73.
CONMED (NASDAQ:CNMD) last announced its earnings results on Wednesday, April 22nd. The company reported $0.42 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.43 by $0.01. The company had revenue of $177.90 million for the quarter, compared to the consensus estimate of $176.16 million. During the same quarter in the previous year, the company posted $0.49 earnings per share. The company’s revenue for the quarter was down 2.2% on a year-over-year basis. On average, analysts predict that CONMED will post $1.85 earnings per share for the current fiscal year.
